Tag: Biotechnology
Gene Therapy offers Cure for Bubble Boy Syndrome
Severe combined immunodeficiency (SCID) or “Bubble Boy Syndrome” is a rare genetic disorder caused by gene mutations that inhibit the functioning of immune cells....
Share Skyrockets on news of positive early-stage results from GEN-009 Clinical...
Genocea Biosciences, Inc. (NASDAQ: GNCA) skyrocketed today based on news of promising data from its early stage clinical trials of GEN-009, its neoantigen vaccine candidate....
Can Cara Therapeutics buck the trend?
Cara Therapeutics (NASDAQ: CARA) recently posted its first quarter, 2019 results. The company reported a net loss of $22.0 million, or $0.56 per basic...
Research in Clonidine shows promise in the treatment of Sciatica
Sciatica also known as lumbosacral radiculopathy or radicular leg pain is a chronic pain condition that affects approximately 1 in 20 adults each year...
MUSTANG BIO: SOARING TO A NEW HIGH AFTER BUBBLE BOY CURE...
Mustang Bio’s (NASDAQ: MBIO) shares rose by almost 250% after its development partner, St Jude Children’s Research Hospital in Memphis, published study results that...
A paradigm shift in the ACNE treatment industry?
Acne is one of the most common skin disorders in the U.S affecting over 50 million people annually. An estimated 85% of young adults aged between...
BXT-25 – CAN BIOXYTRAN INC’S NOVEL DRUG REVOLUTIONIZE OXYGEN DELIVERY?
Ponder this!
In the event of a brain stroke, the brain loses 32,000 neurons, 230 million synapses, 200 meters/220 yards of myelinated fibers and ages...
5 Promising Companies In The Non-Opioid Drug Industry
Chronic Pain is the leading cause for seeking medical aid in the U.S. A study undertaken by the Centres for disease control and prevention...
We are looking for talented interns to learn and help investors find valuable companies.